Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Slow-acting, disease-modifying osteoarthritis agents

P S McNamara1, S A Johnston, R J Todhunter

  • 1Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.

The Veterinary Clinics of North America. Small Animal Practice
|July 1, 1997
PubMed
Summary

Tetracyclines may offer benefits for osteoarthritis (OA) beyond their antibiotic properties by inhibiting metalloproteinases. Further clinical studies are needed to confirm their disease-modifying potential in OA treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterisation of respiratory mechanics in adults with CF using dynamic chest radiography.

Clinical radiology·2025
Same author

Zebrafish Larvae as an Experimental Model of Cryptococcal Meningitis.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Technology of Informative Feature Selection for Immunosignature Analysis.

Sovremennye tekhnologii v meditsine·2021
Same author

First Report of Powdery Mildew in Greenhouse-Grown Tomatoes in New Jersey.

Plant disease·2019
Same author

An Assessment of Fungicide Benefits for the Control of Fungal Diseases of Processing Tomatoes in New York and New Jersey.

Plant disease·2019
Same author

Experiences of rosacea and its treatment: an interpretative phenomenological analysis.

The British journal of dermatology·2017

Area of Science:

  • Pharmacology
  • Rheumatology
  • Veterinary Medicine

Background:

  • Tetracyclines possess non-antimicrobial properties.
  • Metalloproteinase inhibition is a potential mechanism for disease modification in osteoarthritis (OA).

Purpose of the Study:

  • To evaluate the potential disease-modifying effects of tetracyclines in osteoarthritis.
  • To assess the current evidence supporting tetracycline use for OA treatment.

Main Methods:

  • Review of existing literature on tetracyclines and osteoarthritis.
  • Analysis of in vivo studies, particularly canine models of OA.

Main Results:

  • Evidence suggests tetracyclines inhibit metalloproteinases, indicating a potential therapeutic benefit in OA.

Related Experiment Videos

  • Canine cruciate ligament transection models provide the most compelling in vivo data for oral tetracycline efficacy in OA.

    • Conclusions:

    • Tetracyclines show promise as a disease-modifying agent for OA due to metalloproteinase inhibition.
    • Current evidence, while suggestive, is insufficient; controlled clinical trials are required.
    • The use of tetracyclines for OA remains investigational pending further research.